Nano-X Imaging (NASDAQ:NNOX) CEO Erez Meltzer Acquires 25,000 Shares of Stock

Nano-X Imaging Ltd. (NASDAQ:NNOX) CEO Erez Meltzer bought 25,000 shares of the business’s stock in a transaction dated Monday, October 19th. The shares were purchased at an average price of $0.45 per share, for a total transaction of $11,250.00. Following the transaction, the chief executive officer directly owned 90,443 shares of the company’s stock, valued at approximately $40,699.35. This represents a 38.20% increase in their position. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink.

Erez Meltzer also recently made the following trade(s):

• On Tuesday, September 15th, Erez Meltzer bought 10,000 shares of Nano-X Imaging stock. The stock was purchased at an average cost of $0.69 per share, with a total value of $6,900.00.
• On Thursday, September 10th, Erez Meltzer bought 10,000 shares of Nano-X Imaging stock. The stock was purchased at an average cost of $0.78 per share, with a total value of $7,800.00.
• On Monday, August 10th, Erez Meltzer bought 9,443 shares of Nano-X Imaging stock. The stock was purchased at an average cost of $1.03 per share, with a total value of $9,726.29.
• On Monday, July 27th, Erez Meltzer purchased 36,000 shares of Nano-X Imaging stock. The shares were purchased at an average price of $0.93 per share, for a total transaction of $33,480.00.

Nano-X Imaging Stock Up 0.8%

NASDAQ:NNOX opened at $0.41 on Wednesday. The company has a market capitalization of $32.48 million, a PE ratio of -0.19 and a beta of 1.28. Nano-X Imaging Ltd. has a 52-week low of $0.36 and a 52-week high of $4.71. The stock’s 50 day moving average price is $0.73 and its 200 day moving average price is $1.30.

Nano-X Imaging (NASDAQ:NNOX) last issued its quarterly earnings data on Wednesday, September 9th. The company reported ($0.79) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.16) by ($0.63). The firm had revenue of $4.16 million during the quarter, compared to analysts’ expectations of $5.38 million. Nano-X Imaging had a negative net margin of 926.05% and a negative return on equity of 116.93%. As a group, sell-side analysts anticipate that Nano-X Imaging Ltd. will post -1.23 EPS for the current fiscal year.

Hedge Funds Weigh In On Nano-X Imaging

Several institutional investors have recently bought and sold shares of NNOX. Engineers Gate Manager LP acquired a new stake in shares of Nano-X Imaging in the 2nd quarter worth $42,000. Squarepoint Ops LLC purchased a new stake in shares of Nano-X Imaging in the second quarter valued at about $66,000. PCM Encore LLC purchased a new stake in shares of Nano-X Imaging in the second quarter valued at about $53,000. Bank of America Corp DE increased its stake in shares of Nano-X Imaging by 711.1% during the first quarter. Bank of America Corp DE now owns 484,328 shares of the company’s stock worth $1,099,000 after acquiring an additional 424,618 shares during the period. Finally, Royal Bank of Canada increased its stake in shares of Nano-X Imaging by 27.8% during the first quarter. Royal Bank of Canada now owns 194,166 shares of the company’s stock worth $440,000 after acquiring an additional 42,273 shares during the period. 21.49% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts recently commented on the stock. Cantor Fitzgerald reiterated an “overweight” rating and issued a $5.00 price target on shares of Nano-X Imaging in a research report on Monday, August 17th. Weiss Ratings reissued a “sell (e+)” rating on shares of Nano-X Imaging in a research report on Friday, October 2nd. Finally, Alliance Global Partners lowered shares of Nano-X Imaging from a “buy” rating to a “neutral” rating and dropped their price objective for the company from $5.00 to $3.00 in a research note on Tuesday, July 7th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Nano-X Imaging presently has an average rating of “Moderate Buy” and a consensus price target of $4.33.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. is a medical technology company developing digital X-ray and medical imaging solutions. Its primary product is the Nanox.ARC, a digitally driven X-ray system designed to provide imaging capabilities in hospitals, clinics and other healthcare settings. The company’s approach is intended to support more accessible and affordable diagnostic imaging, including in locations where conventional radiology infrastructure may be limited.

Nano-X also offers cloud-based services through its Nanox.CLOUD platform, which is designed to connect imaging devices, manage examinations and facilitate the transmission and review of medical images.